Francina Agosti News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Receives $1 2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Receives $1 2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New south walesFrancina agostiBrianm stremCalifornia newsfile corpKiora pharmaceuticals incKiora pharmaceuticalsRetinitis pigmentosaOcular presentationRheumatoid arthritisDihydroorotate dehydrogenasePrivate securities litigation reform actAnnual report

Kiora Pharmaceuticals Receives $1 2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease

Kiora Pharmaceuticals Receives $1 2 Million in Research Tax Credits to Advance the Treatment of Ophthalmic Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New south walesBrianm stremFrancina agostiKiora pharmaceuticalsKiora pharmaceuticals incCalifornia newsfile corpRetinitis pigmentosaOcular presentationRheumatoid arthritisDihydroorotate dehydrogenasePrivate securities litigation reform actAnnual report

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Announces Closing of $6 3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Encinitas, California (Newsfile Corp. - June 6, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the closing of an underwritten public offering for gross

Mecklenburg vorpommernUnited statesNew yorkFrancina agostiStefan klotterKiora pharmaceuticals incKiora pharmaceuticalsExchange commissionCalifornia newsfile corpProspectus departmentLadenburg thalmann coSeriesf convertible preferred stockClassc warrantClassd warrantClassc warrantsClassd warrants

Kiora Pharmaceuticals Announces Closing of $6 3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Kiora Pharmaceuticals Announces Closing of $6 3 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkFrancina agostiKiora pharmaceuticalsKiora pharmaceuticals incLadenburg thalmann coExchange commissionCalifornia newsfile corpProspectus departmentWall streetSeriesf convertible preferred stockClassc warrantClassd warrantClassc warrantsClassd warrantsUnited states securities

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Announces Pricing of $5 5 Million Underwritten Public Offering

Encinitas, California (Newsfile Corp. - June 2, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the pricing of an underwritten public offering for gross

New yorkUnited statesFrancina agostiExchange commissionProspectus departmentLadenburg thalmann coKiora pharmaceuticals incCalifornia newsfile corpKiora pharmaceuticalsSeriesf convertible preferred stockClassc warrantClassd warrantClassc warrantsClassd warrantsUnited states securitiesLadenburg thalmann